A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies (NCT06208878)

CRSP-ONC-LTF

This trial is Coming soon
Registration number NCT06208878
This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies.

Program & service

This trial is being run with the Cancer service, and as part of the Haematology program.

Trial phase

Other

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Prof Constantine Tam

Key inclusion data

Subjects who are enrolled in a parent study and were exposed to allogeneic CRISPR CAR T cellular therapy will be asked to participate in this Long Term Follow Up study.

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.